G. David Roodman

  • 23334 Citations
  • 80 h-Index
1975 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where G. David Roodman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Osteoclasts Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Bone Diseases Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences
Bone Resorption Medicine & Life Sciences
Bone Chemical Compounds
Osteitis Deformans Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1978 2020

Bone Diseases
Multiple Myeloma
zoledronic acid
Mesenchymal Stromal Cells
Bone Diseases
Multiple Myeloma
Vitamin D
Calcitriol Receptors
Multiple Myeloma
Bone and Bones

Publications 1975 2019

Aplidin (plitidepsin) is a novel anti-myeloma agent with potent anti-resorptive activity mediated by direct effects on osteoclasts

Delgado-Calle, J., Kurihara, N., Atkinson, E. G., Nelson, J., Miyagawa, K., Galmarini, C. M., Roodman, G. D. & Bellido, T., Apr 12 2019, In : Oncotarget. 10, 28, p. 2709-2721 13 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Bone Development
2 Citations (Scopus)

The role of cement augmentation with percutaneous vertebroplasty and balloon kyphoplasty for the treatment of vertebral compression fractures in multiple myeloma: a consensus statement from the International Myeloma Working Group (IMWG)

Kyriakou, C., Molloy, S., Vrionis, F., Alberico, R., Bastian, L., Zonder, J. A., Giralt, S., Raje, N., Kyle, R. A., Roodman, G. D., Dimopoulos, M. A., Rajkumar, S. V., Durie, B. B. G. & Terpos, E., Mar 1 2019, In : Blood Cancer Journal. 9, 3, 27.

Research output: Contribution to journalArticle

Open Access
Compression Fractures
Multiple Myeloma
3 Citations (Scopus)

A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America

Raje, N., Roodman, G. D., Willenbacher, W., Shimizu, K., García-Sanz, R., Terpos, E., Kennedy, L., Sabatelli, L., Intorcia, M. & Hechmati, G., Mar 6 2018, (Accepted/In press) In : Journal of Medical Economics. p. 1-12 12 p.

Research output: Contribution to journalArticle

zoledronic acid
Multiple Myeloma
Cost-Benefit Analysis
Costs and Cost Analysis
Disease-Free Survival
4 Citations (Scopus)

Bones in Multiple Myeloma: Imaging and Therapy

Zamagni, E., Cavo, M., Fakhri, B., Vij, R. & Roodman, G. D., May 23 2018, In : American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 38, p. 638-646 9 p.

Research output: Contribution to journalReview article

Bone Diseases
Multiple Myeloma
Disease Management
Bone and Bones
RANK Ligand

Cancer and bone

Guise, T. & Roodman, G. D., Jan 1 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. wiley, p. 737-738 2 p.

Research output: Chapter in Book/Report/Conference proceedingForeword/postscript

Bone Neoplasms